| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |

From the Mario Negri Institute for Pharmacological
Research,*
Bergamo; and the Unit of Nephrology and
Dialysis,
Azienda Ospedaliera, Ospedali
Riuniti di Bergamo, Bergamo, Italy
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
We have designed the present study to explore: 1) whether proteinuria has any role in tubular atrophy and glomerular-tubule disconnection; and 2) whether treatment with an ACE inhibitor influences tubular atrophy and disconnection independently from the effect on systemic blood pressure control. Studies were performed in rats with passive Heymann nephritis (PHN), an experimental model of human membranous nephropathy.
| Materials and Methods |
|---|
|
|
|---|
Male Sprague-Dawley rats (Charles River Italia s.p.a., Calco, Italy) with initial body weights of 250 to 300 g were used in this study. Animal care and treatment were conducted in accordance with the institutional guidelines that are in compliance with national (D.L. n.116, G.U., suppl.40, 18 feb. 1992, Circolare N°8, G.U., 14 Luglio 1994) and international laws and policies (EEC Council Directive 86/609, OJL358-1, December 1987; Guide for the Care and Use of Laboratory Animals, U.S. National Research Council, 1996). All animals were housed in a room in which the temperature was kept constant on a 12-hour dark/12-hour light cycle and allowed free access to standard diet containing 20% protein by weight and tap water. PHN was induced in nonanesthetized rats by a single intravenous injection of 0.4 ml/100 g body wt of rabbit anti-Fx1A antibody. Seven days later, when proteinuria was already present, the animals were subjected to right unilateral nephrectomy to accelerate the onset of renal damage. Accelerated PHN is a very severe model of nephrotic syndrome in which ACE inhibitor treatment is not uniformly effective in reducing proteinuria.10 Animals were divided into four groups: group 1 (n = 4) and group 2 (n = 8): untreated PHN rats followed for 4 or 8 months after PHN induction, group 3 (n = 7) rats given the ACE inhibitor lisinopril (40 mg/L) from day 7 after PHN induction in the drinking water to month 8, group 4 (n = 5) rats treated with the dihydropyridinic calcium antagonist lacidipine (3 mg/kg) by gavage, from day 7 after surgery to month 8. Previous studies have documented that this lacidipine dose is effective in reducing blood pressure throughout a 24-hour observation period.11 Two additional groups of rats (groups 5 and 6, n = 4), considered as controls, underwent right unilateral nephrectomy and were sacrificed at 4 and 8 months. In all rats the systolic blood pressure, 24-hour urinary protein excretion, and serum creatinine levels were measured at the end of the study. At sacrifice, the kidneys were removed from anesthetized animals for histological and morphological studies. A range of 40 to 46 glomeruli was examined in each animal. One hundred eighty-five glomeruli in group 1, 319 in group 2, 224 in group 3, 225 in group 4, and 180 in group 5 and 6 were studied.
Analyticals
Systolic blood pressure was recorded by tail plethysmography in conscious rats.12 Twenty-four hour samples were collected using metabolic cages and proteinuria was determined by modified Coomassie blue G dye-binding assay for proteins with bovine serum albumin as standard.13
Blood was collected from the tail vein of anesthetized animals. Serum was obtained after whole blood clotting and kept frozen at -20°C until assayed. Creatinine was measured by the alkaline picrate method.14
Renal Histology
The removed kidneys were fixed for 6 hours in Dubosq-Brazil, dehydrated in alcohol, and embedded in paraffin. Sections of renal tissue (3 µm) were stained with Massons trichrome, hematoxylin and eosin, and periodic acid-Schiff reagent. Sections including superficial and juxtamedullary glomeruli were evaluated. Tubular (atrophy, casts, and dilatation) and interstitial changes (fibrosis and inflammation) were graded from 0 to 4+ (0, no changes; 1+, changes affecting <25% of the sample; 2+, changes affecting 25 to 50% of the sample; 3+, changes affecting 50 to 75% of the sample; 4+, changes affecting 75 to 100% of the sample). At least 100 glomeruli were examined for each animal and the extent of glomerular damage was expressed as the percentage of glomeruli presenting focal or global sclerotic lesions. All renal biopsies were analyzed by the same pathologist who was unaware of the nature of the experimental groups.
Morphometric Analysis
Kidney samples fixed in Dubosq-Brazil and embedded in paraffin
were serially sectioned at 3-µm intervals and three sections per
slide were mounted and stained with periodic acid-Schiff reagent. A
video camera (Panasonic, Matsushita Elect. Co., Osaka, Japan) connected
to a light microscope and a computer was used. The sections under the
microscope were simultaneously visualized on the computer display. An
average of 78 sections for each rat was examined. Figure 1
summarizes the procedures for
evaluation of glomerular-tubule connections in individual glomeruli and
fractional interstitial volume. The section in the middle of the series
(39th) was photographed and used as a map of the serial sections. This
map served as a guide to light microscopic examination to identify the
individual glomeruli that were followed in the other sections. Only
those glomeruli contained entirely within the serially sectioned tissue
were examined. Glomerular populations ranging from 180 to 319 depending
on the animal group were examined through all the sections before and
after the map section. Glomeruli were classified as connected to a
normal proximal tubule, connected to an atrophic proximal tubule, or
without a tubular connection (Figure 1)
. Proximal tubule segments
connected to glomeruli were considered atrophic when there was thinning
of tubular cells accompanied by loss of brush border and narrowing of
the tubular lumen. The findings were expressed as percentage of the
three categories of glomeruli over the total number of glomeruli
examined. The fractional volume of the cortex occupied by the
interstitium was measured by point counting using a 10 x 10
orthogonal grid overlaid on the digital image on the computer monitor
at magnification of x1200. In each case, a minimum of 3000 points in
three sections at least 100 µ apart were counted, and the fractional
volumes of the interstitium were expressed as the percentages of points
falling on these structural components.
|
TUNEL assay for the detection of apoptosis was performed on Dubosq-Brazil-fixed and paraffin-embedded renal sections. Apoptosis was evaluated in three sections at least 9 µ apart in all PHN animals at 8 months. Briefly, 3-µm sections were deparaffinized and treated with 20 µg/ml of proteinase K for 10 minutes at 37°C. After two washes with phosphate-buffered saline (PBS) endogenous peroxidase activity of kidney sections was blocked by incubation with 0.3% H2O2 in PBS for 15 minutes. Then, sections were incubated with the TUNEL reaction mixture (Roche Diagnostic, Mannheim, Germany) containing terminal deoxynucleotidyl transferase and fluorescein isothiocyanate-labeled nucleotide mixture for 60 minutes at 37°C in the dark. Sheep anti-fluorescein antibody conjugated with peroxidase (TUNEL Pod; Boehringer-Mannheim, Mannheim, Germany) was added for 30 minutes at 37°C and finally developed with diaminobenzidine. Sections were then counterstained with Harris hematoxylin (Biooptica, Milan, Italy). Negative control was obtained by omitting terminal deoxynucleotidyl transferase in TUNEL reaction mixture while positive control with the addition of DNase for 15 minutes at 37°C.
Statistical Analysis
Food and water intake, body and kidney weight, and blood pressure data are given as mean ± SD. All of the other data are reported as median value (interquartile range). One way-analysis of variance followed by Tukey test for multiple comparisons was used to compare experimental groups. Morphometric data were analyzed by the nonparametric Kruskal-Wallis test. Pearson correlation coefficient was used to assess the relationship between urinary protein excretion or systolic blood pressure and morphometric parameters (percent atubular glomeruli and fractional interstitial volume) in all groups of rats. Multivariate analysis was performed using multiple linear regression.15 The statistical significance level was defined as P < 0.05.
| Results |
|---|
|
|
|---|
All animals in the experimental groups survived the duration of
the study. Total food intake was comparable in all PHN and control rats
for the entire study period. The average food intake at sacrifice was:
PHN 4 months: 24.3 ± 7.8; PHN 8 months: 25 ± 2.2; PHN 8
months lisinopril: 26.8 ± 4.0; PHN 8 months lacidipine: 25
± 2.9; controls 4 months: 20.8 ± 2.6; 8 months: 26 ± 2.5
g/day. Water intake was 55 ± 13 ml/day in PHN at 4 months. At
month 8 all PHN animals had an increase in water intake over controls
independently of treatment (PHN, 66 ± 15.1; PHN and lisinopril,
59 ± 12.5; PHN and lacidipine, 70 ± 12.2 versus
controls 4 months, 43.8 ± 9.5; 8 months, 40 ± 10 ml/day).
Rats with PHN gained weight along the study; however, at 8 months body
weight was numerically, but not significantly, lower than controls (PHN
8 months, 614 ± 53; controls, 686 ± 73 g). Treatments
of PHN rats did not affect the weight gain (PHN 8 months lisinopril,
622 ± 49; PHN 8 months lacidipine, 593 ± 80 g).
Hypertrophy of the left kidney was observed already at 4 months in PHN
rats (PHN 4 months, 4.1 ± 1 g) and persisted at month 8
(4.2 ± 1.1 versus controls, 3.0 ± 0.4 g).
Lisinopril, but not lacidipine, decreased left kidney hypertrophy to a
significant extent (PHN 8 months lisinopril, 3.6 ± 0.6 g;
P < 0.05 versus PHN 8 months, PHN 8 months
lacidipine, 4.3 ± 0.5 g). As shown in Table 1
, in untreated PHN rats systolic blood
pressure increased throughout time reaching values at month 8 that were
significantly higher than controls (P < 0.05).
Both lisinopril and lacidipine prevented (P <
0.05) the increase in systolic blood pressure. Lisinopril and
lacidipine maintained systolic blood pressure at levels that were not
significantly different from those of controls (Table 1)
. Values of
urinary protein excretion are given in Table 1
. PHN rats showed
significant proteinuria at month 4 (P < 0.05
versus controls). Urinary protein excretion further rose at
month 8 in untreated PHN rats in respect to controls
(P < 0.05). The median value of proteinuria in
the lisinopril-treated group was significantly
(P < 0.05) lower than that of untreated PHN,
the ACE inhibitor being effective in significantly limiting proteinuria
in five out of seven PHN animals. In contrast, the calcium antagonist
did not affect the development of proteinuria. Urinary protein levels
in lacidipine-treated animals were comparable to untreated PHN rats.
PHN rats developed a mild renal insufficiency at month 4. Renal
function was significantly impaired starting from month 8
(P < 0.05 versus controls). In PHN
animals given lisinopril, serum creatinine was numerically lower than
in untreated PHN, the difference, however, did not reach statistical
significance because of the presence of two animals that did not
respond to ACE inhibition. Furthermore, PHN rats given lacidipine
exhibited high levels of serum creatinine comparable to those of
untreated PHN rats. The results of renal histology are reported in
Table 1
. The percentage of sclerotic glomeruli and the score of
interstitial damage were significantly increased in untreated PHN rats
at months 4 and 8 in respect to controls (P <
0.05). The value of tubular damage was significantly increased
(P < 0.05) over controls at month 8. Lisinopril
strikingly protected animals from the development of glomerular and
tubular structural injury as indicated by a median value of
glomerulosclerosis of 9% and the score for tubulointerstitial damage
similar to that of controls. By contrast, lacidipine did not affect the
development of glomerulosclerosis and tubulointerstitial lesions.
|
Kidneys of PHN rats at month 4 showed tubular injury characterized
by mild dilation, atrophy, and luminal casts. Tubular changes were
associated with interstitial mononuclear cell accumulation and
fibrosis. As shown in Table 2
, by month 4
there was a remarkable increase in the prevalence of atubular glomeruli
and glomeruli connected with atrophic tubuli with reduced lumen size,
thickened basement membrane, and without brush border compared to
controls. Stenosis of tubular neck was similar to that described in a
radiation model of chronic renal failure.16
At month 8,
tubulointerstitial changes consisted of severe tubular atrophy,
interstitial fibrosis, and inflammation, were associated with the
presence of large proteinaceous casts in tubular lumens. Within the
glomerular population, the number of glomeruli connected with a normal
tubule significantly (P < 0.01) decreased in
PHN rats at month 8 over month 4, both values were significantly
different from those of respective controls (PHN 4 months,
P < 0.05; PHN 8 months, P < 0.01;
Table 2
). Concomitantly, a further and significant
(P < 0.01) increase in the percentage of
atubular glomeruli and glomeruli connected with atrophic tubules was
observed at month 8 in respect to month 4. Altogether, almost three
quarters of the glomerular population were no longer connected to
normal proximal tubules. Lisinopril prevented the disconnection of
glomeruli from tubules and the appearance of atrophic tubules. The
median value of atubular glomeruli in lisinopril-treated PHN rats was
comparable to the values of control animals. In the two PHN rats that
did not respond to the ACE inhibitor, atubular glomeruli and glomeruli
with an atrophic tubule were observed. Lacidipine did not affect the
percentage of atubular glomeruli and glomeruli connected with atrophic
tubules with respect to untreated PHN animals at month 8. Fractional
interstitial volume significantly increased in PHN rats at month 4 with
respect to controls (P < 0.05), and further
rose at month 8 (P < 0.01 versus PHN
4 months and controls). Median fractional interstitial volume was
significantly reduced in the lisinopril-treated groups
(P < 0.05). Interstitial volume was even
normalized in animals whose proteinuria was effectively lowered by the
ACE inhibitor. In contrast, lacidipine treatment did not affect
fractional interstitial volume, which was not statistically different
from PHN at month 8.
|
|
Evidence that albumin overload in vitro and in
vivo results in marked apoptosis of tubular epithelial
cells,7,8
together with the observation of the presence of
albumin and IgG reabsorption droplets in proximal tubular cells of PHN
rats,5
prompted us to evaluate apoptosis in glomeruli
connected to a normal or an atrophic tubule in all PHN rats at 8
months. Three sections of each animal were evaluated. No positive or a
very mild TUNEL staining in occasionally few cells was observed in
tubuli normally connected to the glomerulus. By contrast, a strong
TUNEL staining was invariably detected in tubular cells of all atrophic
tubules that also showed a flattened appearance, scarce cytoplasm, and
no recognizable brush border. This latter findings are in line with a
very recent observation of positively stained nuclei of apoptotic cells
in atrophic tubules of rats with subtotal nephrectomy.17
Figure 2
shows representative
photomicrographs of proximal tubules normally connected to a glomerulus
and an atrophic tubule.
|
| Discussion |
|---|
|
|
|---|
Glomerular-tubule disconnection has been reported in several experimental models such as radiation nephropathy18 or nephropathy induced by tubular toxic substances such as lithium19 and cisplatin20 and also in patients with chronic allograft rejection.21 In lithium-induced nephropathy of newborn rats, the noxious agent was administered during the developing phase of the kidney,19 which is obviously more vulnerable to the toxic substances. In the model of cisplatin toxicity of adult rats, damage of specific segments of the tubules clearly preceded tubular atrophy, which in turn determined glomerular-tubule disconnection.20 In a model of renal mass ablation, Gandhi and colleagues4 also reported that declining renal function with time paralleled tubular atrophy and disconnection and suggested that the process of protein handling by the kidney could play a role. This possibility is entirely consistent with previous findings, that in the remnant kidney, renal injury correlated more closely with proteinuria than with the fraction of renal mass removed.22,23
Here, in a model that mimics chronic proteinuric diseases in humans10 much more closely than the remnant kidney, we found a highly significant correlation between the amount of protein excreted in the urine and the percentage of atubular glomeruli. After excessive glomerular ultrafiltration of plasma proteins, tubule over-reabsorption activates an intracellular program of up-regulation of vasoactive and inflammatory genes, which has been extensively studied in the past 10 years in the context of interstitial inflammation and fibrosis.5,6,24,25 It is possible that the above changes promote a progressive obliteration of peritubular capillaries, which in turn serve to disconnect proximal tubuli from their corresponding glomeruli.23,24,26,27 This is in harmony with human data that show a positive correlation between the volume fraction of the interstitium and the percentage of proximal tubuli without connection to a glomerulus.28 An alternative mechanism is that tubular protein reabsorption can directly induce proapoptotic gene activation, thus favoring tubular atrophy and disconnection. This possibility has received a strong support by findings that albumin overload dose and time-dependently induced apoptosis of cultured proximal tubular cells and resulted in up-regulation of pro-apoptotic Fas and Fas-associated protein with death domain and activation of caspase 8.7 Data in rats with overload proteinuria are also in favor of the above possibility, to the extent that significantly more apoptotic particles were found in cortical and medullary tubular cells, as compared to control rats.8 The present findings of a strong TUNEL staining in atrophic tubules of PHN rats, but not in tubuli normally connected to glomeruli, which parallels tubular protein accumulation, indicate that indeed protein handling may favor apoptosis and subsequent injury.
When rats with PHN were given lisinopril, which limits proteinuria by restoring the size-selective properties of the glomerular filter,29 tubular atrophy and disconnection were remarkably prevented. PHN animals, which did not respond to ACE inhibition in terms of reduction of proteinuria, had a glomerular population consisting mainly of atubular glomeruli and glomeruli connected with atrophic tubules, which again would seem consistent with the possibility that excessive protein handling favors disconnection. The present results are at variance to those of a previous study showing that reduction in AII activity did not prevent tubule loss during the early and late phase of recovery from acute ischemia despite AII blockade primarily prevented the development of proteinuria.30 Differences between the animal models as for the type of glomerular injury, which in this latter study was secondary to acute ischemia, and treatment mode could account for opposing results. On the other hand, a protective effect of ACE inhibitors was been recently described in radiation nephropathy, characterized by glomeruli with stenosis of glomerulotubular neck and atubular glomeruli.18 In this study although captopril did not influence the absolute fraction of necks that were stenotic, it did prevent the evolution of glomeruli with necks to atubular glomeruli. The ACE inhibitors renoprotection has been attributed to their systemic antihypertensive effect that translates to the reduction of glomerular capillary hypertension. Here, we formally compared the effect of lisinopril with that of the dihydropyridinic calcium antagonist lacidipine, which is equally effective on systemic blood pressure but does not affect urinary protein excretion rate. The results indicated that lacidipine-treated animals had a high percentage of atubular glomeruli and glomeruli connected with atrophic tubules. Multivariate analysis of all of the available data found that tubular injury and disconnection were better predicted by proteinuria than by blood pressure. Whether the observed tubular changes were the consequence of a diverse effect of the two study drugs on glomerular pressure could not be excluded. In this context, conflicting results on the effect of calcium channel blocker on intrarenal hemodynamics derived from micropuncture studies. Data in uninephrectomized diabetic rats has shown that fosinopril, but not nifedipine, normalized glomerular capillary pressure and increased Kf.31 However, studies in the remnant kidney model indicated that verapamil was also effective.32,33 In the present study, micropuncture experiments were not performed for the lack of superficial glomeruli in the animal strain. Further studies are needed to definitely address the different effect of ACE inhibitor and calcium channel blocker on glomerular capillary pressure in PHN rats.
The fractional volume of the cortex occupied by interstitium was markedly increased in PHN rats, and lisinopril reduced both interstitial expansion and disconnection in those rats whose protein excretion was reduced by ACE inhibitors, an effect not shared by lacidipine. Taken together, the present data reinforce the possibility that the extent of interstitial inflammation played a role in the process of disconnection.
In summary, the present study has documented that in the accelerated PHN model 1) a time-dependent increase in urinary protein excretion parallels the emergence of atrophic tubules and glomerular-tubule disconnection and the expansion of fractional volume of the cortex occupied by the interstitium; 2) atrophic tubuli invariably showed signs of cell apoptosis, which precedes and may favor disconnection; 3) ACE inhibition effectively limits proteinuria and prevents the formation of atrophic tubules, glomerular-tubule disconnection, and the fractional interstitial volume expansion; 4) lacidipine, that does not reduce proteinuria despite an excellent effect on systemic blood pressure, failed to prevent the appearance of atrophic tubules or atubular glomeruli.
The speculation raised by previous studies that proteinuria might be a factor in tubular atrophy and disconnection is suggested by our present results. Findings that an ACE inhibitor, but not lacidipine, prevents glomerular-tubule disconnection disclose a novel mechanism of renoprotection of this class of compounds and may have implications in human renoprotective medicine.
| Acknowledgements |
|---|
| Footnotes |
|---|
E. G. is the recipient of a fellowship in memory of Dott. Luigi and Tilde Bianchi from the "Associazione Ricerca Malattie Rare" (ARMR), Bergamo, Italy.
Accepted for publication July 23, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. L. Chevalier and M. S. Forbes Generation and Evolution of Atubular Glomeruli in the Progression of Renal Disorders J. Am. Soc. Nephrol., February 1, 2008; 19(2): 197 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Theilig, W. Kriz, T. Jerichow, P. Schrade, B. Hahnel, T. Willnow, M. Le Hir, and S. Bachmann Abrogation of Protein Uptake through Megalin-Deficient Proximal Tubules Does Not Safeguard against Tubulointerstitial Injury J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1824 - 1834. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Erkan, P. Devarajan, and G. J. Schwartz Mitochondria Are the Major Targets in Albumin-Induced Apoptosis in Proximal Tubule Cells J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1199 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Forbes, B. A. Thornhill, M. H. Park, and R. L. Chevalier Lack of Endothelial Nitric-Oxide Synthase Leads to Progressive Focal Renal Injury Am. J. Pathol., January 1, 2007; 170(1): 87 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Abbate, C. Zoja, and G. Remuzzi How Does Proteinuria Cause Progressive Renal Damage? J. Am. Soc. Nephrol., November 1, 2006; 17(11): 2974 - 2984. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nangaku, S. J. Shankland, and W. G. Couser Cellular Response to Injury in Membranous Nephropathy J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1195 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Erkan, C. D. Garcia, L. T. Patterson, J. Mishra, M. M. Mitsnefes, F. J. Kaskel, and P. Devarajan Induction of Renal Tubular Cell Apoptosis in Focal Segmental Glomerulosclerosis: Roles of Proteinuria and Fas-Dependent Pathways J. Am. Soc. Nephrol., February 1, 2005; 16(2): 398 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Najafian, Y. Kim, J. T. Crosson, and M. Mauer Atubular Glomeruli and Glomerulotubular Junction Abnormalities in Diabetic Nephropathy J. Am. Soc. Nephrol., April 1, 2003; 14(4): 908 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zoja, D. Corna, D. Camozzi, D. Cattaneo, D. Rottoli, C. Batani, C. Zanchi, M. Abbate, and G. Remuzzi How To Fully Protect the Kidney in a Severe Model of Progressive Nephropathy: A Multidrug Approach J. Am. Soc. Nephrol., December 1, 2002; 13(12): 2898 - 2908. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |